Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced that MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) has joined its Data Syndication Partnership program for the LEARNS observational study, which seeks to develop digital biomarkers in neurodegenerative disorders from smart phone-based assessments and wearable technologies.